# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.449406648170372	Range of duration = 0.92 to 345.96, nDeath = 71, nCensor = 79
2	AGE	ANOVA	0.119803687791756	Range of values = 18 to 87, Mean = 55.9276, StdDev = 15.895
3	PRIMARY.SITE.OF.DISEASE	Fisher's exact test	0.05519723712733	nTypes = 2 (REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 36/116
4	GENDER	Fisher's exact test	0.0810359057307199	nTypes = 2 (FEMALE/MALE), nPatients = 55/97
5	DISTANT.METASTASIS	Chi-square test	0.698693844579165	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 133/1/2/2/1, nMissing = 13
6	LYMPH.NODE.METASTASIS	Chi-square test	0.417787445524275	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 78/2/7/12/1/4/12/4/18/2, nMissing = 12
7	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 152
8	NEOPLASM.DISEASESTAGE	Chi-square test	0.402546815176362	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/16/8/14/17/7/8/4/9/5/17/23/4, nMissing = 19